 Megan Kelsey
Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 32 | 2023 | 2031 | 4.680 |
Why?
| | Insulin Resistance | 16 | 2023 | 1163 | 3.890 |
Why?
| | Puberty | 9 | 2021 | 136 | 3.790 |
Why?
| | Pediatric Obesity | 12 | 2021 | 435 | 3.750 |
Why?
| | Hypoglycemic Agents | 8 | 2022 | 1026 | 2.110 |
Why?
| | Bariatric Surgery | 7 | 2022 | 162 | 1.650 |
Why?
| | Obesity, Morbid | 8 | 2022 | 184 | 1.640 |
Why?
| | Metformin | 6 | 2021 | 291 | 1.560 |
Why?
| | Obesity | 15 | 2023 | 2711 | 1.470 |
Why?
| | Adolescent | 52 | 2023 | 18902 | 1.440 |
Why?
| | Prediabetic State | 6 | 2021 | 227 | 1.430 |
Why?
| | Body Mass Index | 14 | 2022 | 2076 | 1.280 |
Why?
| | Insulin-Secreting Cells | 3 | 2021 | 315 | 1.190 |
Why?
| | Adolescent Behavior | 3 | 2020 | 496 | 1.070 |
Why?
| | Health Behavior | 3 | 2020 | 711 | 1.010 |
Why?
| | Child | 39 | 2022 | 18649 | 0.990 |
Why?
| | Testosterone | 5 | 2020 | 333 | 0.920 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 10 | 0.910 |
Why?
| | Blood Glucose | 12 | 2021 | 1904 | 0.900 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 19 | 0.900 |
Why?
| | Body Composition | 4 | 2021 | 765 | 0.840 |
Why?
| | Menstruation Disturbances | 1 | 2018 | 13 | 0.700 |
Why?
| | Cardiovascular Diseases | 6 | 2020 | 1717 | 0.690 |
Why?
| | Insulin | 6 | 2021 | 2138 | 0.690 |
Why?
| | Gonadal Steroid Hormones | 1 | 2019 | 118 | 0.690 |
Why?
| | Polycystic Ovary Syndrome | 4 | 2021 | 159 | 0.680 |
Why?
| | Transgender Persons | 1 | 2020 | 106 | 0.670 |
Why?
| | Adipose Tissue | 3 | 2021 | 665 | 0.640 |
Why?
| | Female | 46 | 2023 | 63247 | 0.640 |
Why?
| | Humans | 61 | 2023 | 117633 | 0.610 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 999 | 0.590 |
Why?
| | Body Weight | 1 | 2020 | 990 | 0.580 |
Why?
| | Male | 39 | 2023 | 60403 | 0.580 |
Why?
| | Glucose Tolerance Test | 6 | 2021 | 366 | 0.580 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2022 | 3258 | 0.540 |
Why?
| | Brain Neoplasms | 1 | 2022 | 976 | 0.510 |
Why?
| | Sex Factors | 4 | 2019 | 1918 | 0.510 |
Why?
| | Cross-Sectional Studies | 10 | 2021 | 4630 | 0.500 |
Why?
| | Leptin | 1 | 2015 | 236 | 0.480 |
Why?
| | Muscle Fatigue | 1 | 2014 | 95 | 0.480 |
Why?
| | Task Performance and Analysis | 1 | 2014 | 176 | 0.480 |
Why?
| | Thinness | 1 | 2013 | 94 | 0.470 |
Why?
| | Mass Screening | 3 | 2022 | 1081 | 0.460 |
Why?
| | Disease Progression | 1 | 2020 | 2541 | 0.450 |
Why?
| | Off-Label Use | 2 | 2022 | 46 | 0.430 |
Why?
| | Depression | 2 | 2023 | 1196 | 0.410 |
Why?
| | Biomarkers | 4 | 2020 | 3574 | 0.410 |
Why?
| | Cohort Studies | 8 | 2021 | 5112 | 0.390 |
Why?
| | Life Style | 4 | 2021 | 408 | 0.390 |
Why?
| | Metabolic Syndrome | 4 | 2020 | 394 | 0.370 |
Why?
| | Sex Hormone-Binding Globulin | 2 | 2019 | 51 | 0.360 |
Why?
| | Muscle, Skeletal | 3 | 2014 | 1539 | 0.340 |
Why?
| | Reference Values | 2 | 2020 | 835 | 0.340 |
Why?
| | Ribonuclease III | 2 | 2021 | 36 | 0.330 |
Why?
| | Bone Density | 2 | 2023 | 432 | 0.330 |
Why?
| | Weight Gain | 2 | 2022 | 513 | 0.330 |
Why?
| | DEAD-box RNA Helicases | 2 | 2021 | 59 | 0.320 |
Why?
| | Pituitary Neoplasms | 2 | 2021 | 154 | 0.300 |
Why?
| | Case-Control Studies | 6 | 2021 | 3269 | 0.300 |
Why?
| | Fructosamine | 2 | 2016 | 21 | 0.290 |
Why?
| | Deoxyglucose | 2 | 2016 | 53 | 0.290 |
Why?
| | Germ-Line Mutation | 3 | 2021 | 121 | 0.290 |
Why?
| | Estradiol | 2 | 2019 | 465 | 0.290 |
Why?
| | Diabetes, Gestational | 2 | 2023 | 285 | 0.280 |
Why?
| | Serum Albumin | 2 | 2016 | 148 | 0.280 |
Why?
| | Young Adult | 10 | 2023 | 11077 | 0.270 |
Why?
| | Gastrointestinal Microbiome | 2 | 2021 | 478 | 0.260 |
Why?
| | Follow-Up Studies | 7 | 2023 | 4911 | 0.260 |
Why?
| | Radius | 2 | 2023 | 34 | 0.250 |
Why?
| | Hypoglycemia | 2 | 2019 | 387 | 0.250 |
Why?
| | Glucose Clamp Technique | 2 | 2015 | 203 | 0.250 |
Why?
| | Risk Factors | 6 | 2023 | 9124 | 0.240 |
Why?
| | Age Factors | 3 | 2021 | 3223 | 0.240 |
Why?
| | Aging | 1 | 2014 | 1690 | 0.240 |
Why?
| | Longitudinal Studies | 3 | 2023 | 2668 | 0.230 |
Why?
| | Colorado | 4 | 2020 | 4401 | 0.220 |
Why?
| | Bariatrics | 1 | 2021 | 5 | 0.220 |
Why?
| | Obesity Management | 1 | 2021 | 7 | 0.220 |
Why?
| | Blast Crisis | 1 | 2021 | 19 | 0.210 |
Why?
| | Hypertension | 2 | 2021 | 1202 | 0.210 |
Why?
| | Anti-Obesity Agents | 1 | 2021 | 43 | 0.210 |
Why?
| | Sleep | 2 | 2018 | 772 | 0.210 |
Why?
| | Overnutrition | 1 | 2021 | 45 | 0.210 |
Why?
| | Bone and Bones | 1 | 2023 | 267 | 0.200 |
Why?
| | Hypogonadism | 1 | 2010 | 74 | 0.200 |
Why?
| | Iatrogenic Disease | 1 | 2020 | 48 | 0.200 |
Why?
| | Hyperinsulinism | 1 | 2021 | 109 | 0.200 |
Why?
| | Treatment Outcome | 6 | 2021 | 9353 | 0.200 |
Why?
| | Diabetic Ketoacidosis | 1 | 2022 | 164 | 0.190 |
Why?
| | Gastric Bypass | 1 | 2021 | 99 | 0.190 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2009 | 7 | 0.190 |
Why?
| | Cushing Syndrome | 1 | 2009 | 10 | 0.190 |
Why?
| | Prognosis | 4 | 2021 | 3549 | 0.190 |
Why?
| | Klinefelter Syndrome | 1 | 2020 | 53 | 0.190 |
Why?
| | Hospitals, Pediatric | 2 | 2022 | 488 | 0.190 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 79 | 0.190 |
Why?
| | Pseudohypoaldosteronism | 1 | 2009 | 2 | 0.190 |
Why?
| | Sexual Maturation | 1 | 2019 | 50 | 0.190 |
Why?
| | Growth Hormone | 1 | 2019 | 107 | 0.190 |
Why?
| | Capillaries | 1 | 2019 | 104 | 0.180 |
Why?
| | Gastrectomy | 1 | 2020 | 78 | 0.180 |
Why?
| | Prospective Studies | 5 | 2021 | 6422 | 0.180 |
Why?
| | Linear Models | 2 | 2019 | 871 | 0.180 |
Why?
| | Vascular Malformations | 1 | 2019 | 42 | 0.180 |
Why?
| | Dyslipidemias | 1 | 2021 | 158 | 0.180 |
Why?
| | Oligonucleotides, Antisense | 1 | 2009 | 100 | 0.180 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 780 | 0.180 |
Why?
| | Hyperkalemia | 1 | 2009 | 28 | 0.180 |
Why?
| | Reproductive Health | 1 | 2019 | 70 | 0.180 |
Why?
| | Exercise | 3 | 2023 | 1809 | 0.180 |
Why?
| | Research | 1 | 2022 | 445 | 0.180 |
Why?
| | Adult | 10 | 2022 | 32118 | 0.180 |
Why?
| | Double-Blind Method | 2 | 2021 | 1695 | 0.180 |
Why?
| | Weight Reduction Programs | 1 | 2019 | 91 | 0.170 |
Why?
| | Drug Therapy, Combination | 2 | 2019 | 1012 | 0.170 |
Why?
| | Exome | 1 | 2019 | 163 | 0.170 |
Why?
| | Psychotherapy, Group | 1 | 2018 | 67 | 0.170 |
Why?
| | Time Factors | 3 | 2021 | 6906 | 0.170 |
Why?
| | Aspartate Aminotransferases | 1 | 2018 | 101 | 0.170 |
Why?
| | Risk Reduction Behavior | 1 | 2020 | 214 | 0.170 |
Why?
| | Fatty Liver | 1 | 2021 | 277 | 0.170 |
Why?
| | Analysis of Variance | 2 | 2019 | 1451 | 0.170 |
Why?
| | Diet | 2 | 2017 | 1115 | 0.160 |
Why?
| | Adenoma | 1 | 2009 | 184 | 0.160 |
Why?
| | Overweight | 1 | 2022 | 495 | 0.160 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2009 | 351 | 0.160 |
Why?
| | Androgens | 1 | 2018 | 161 | 0.160 |
Why?
| | Academic Medical Centers | 1 | 2019 | 414 | 0.150 |
Why?
| | Retrospective Studies | 6 | 2022 | 12331 | 0.150 |
Why?
| | Human Development | 1 | 2016 | 19 | 0.150 |
Why?
| | Depressive Disorder | 1 | 2020 | 384 | 0.150 |
Why?
| | Biodiversity | 1 | 2020 | 357 | 0.150 |
Why?
| | Adiposity | 1 | 2021 | 504 | 0.150 |
Why?
| | United States | 8 | 2022 | 12768 | 0.150 |
Why?
| | Diabetic Nephropathies | 1 | 2019 | 290 | 0.150 |
Why?
| | Hyperglycemia | 2 | 2016 | 330 | 0.150 |
Why?
| | Hydrocortisone | 1 | 2018 | 332 | 0.150 |
Why?
| | Infant | 5 | 2021 | 8255 | 0.140 |
Why?
| | Triglycerides | 2 | 2020 | 551 | 0.140 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2021 | 499 | 0.140 |
Why?
| | Pilot Projects | 1 | 2020 | 1441 | 0.140 |
Why?
| | Adiponectin | 1 | 2016 | 213 | 0.130 |
Why?
| | Neoplasms, Complex and Mixed | 1 | 2014 | 8 | 0.130 |
Why?
| | Infant, Newborn | 3 | 2020 | 5230 | 0.130 |
Why?
| | Sex Characteristics | 1 | 2019 | 681 | 0.130 |
Why?
| | Algorithms | 1 | 2022 | 1550 | 0.130 |
Why?
| | Bacteria | 1 | 2020 | 671 | 0.130 |
Why?
| | Risk | 1 | 2017 | 926 | 0.130 |
Why?
| | Lipolysis | 1 | 2013 | 50 | 0.120 |
Why?
| | Feeding Behavior | 1 | 2018 | 556 | 0.120 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2013 | 20 | 0.120 |
Why?
| | Observer Variation | 1 | 2014 | 326 | 0.120 |
Why?
| | Child, Preschool | 4 | 2021 | 9714 | 0.120 |
Why?
| | Fasting | 1 | 2014 | 273 | 0.120 |
Why?
| | Adolescent Health Services | 1 | 2013 | 65 | 0.120 |
Why?
| | Nutrition Policy | 1 | 2013 | 63 | 0.120 |
Why?
| | Nutrition Assessment | 1 | 2013 | 80 | 0.120 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2013 | 185 | 0.120 |
Why?
| | Electromyography | 1 | 2014 | 336 | 0.110 |
Why?
| | Pediatrics | 1 | 2020 | 1021 | 0.110 |
Why?
| | Gene-Environment Interaction | 1 | 2014 | 209 | 0.110 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2011 | 17 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 963 | 0.110 |
Why?
| | Physical Fitness | 1 | 2013 | 188 | 0.110 |
Why?
| | Biomechanical Phenomena | 1 | 2014 | 711 | 0.100 |
Why?
| | Mutation | 3 | 2019 | 3409 | 0.100 |
Why?
| | Muscle Contraction | 1 | 2014 | 418 | 0.100 |
Why?
| | Weight Loss | 3 | 2021 | 711 | 0.100 |
Why?
| | Potassium Channels | 1 | 2011 | 135 | 0.100 |
Why?
| | Absorptiometry, Photon | 2 | 2023 | 251 | 0.100 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2014 | 468 | 0.100 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2014 | 288 | 0.100 |
Why?
| | Tibia | 2 | 2023 | 171 | 0.100 |
Why?
| | Postoperative Complications | 1 | 2021 | 2113 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2015 | 720 | 0.090 |
Why?
| | Motor Activity | 1 | 2013 | 723 | 0.080 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2023 | 1209 | 0.080 |
Why?
| | Glycation End Products, Advanced | 2 | 2016 | 70 | 0.070 |
Why?
| | Pregnancy | 3 | 2023 | 5554 | 0.060 |
Why?
| | Genome-Wide Association Study | 2 | 2021 | 1036 | 0.060 |
Why?
| | Stomach Neoplasms | 1 | 2004 | 67 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2206 | 0.060 |
Why?
| | Cadherins | 1 | 2004 | 186 | 0.060 |
Why?
| | Comorbidity | 2 | 2021 | 1650 | 0.060 |
Why?
| | Genetic Testing | 1 | 2004 | 383 | 0.050 |
Why?
| | Receptor, Melanocortin, Type 4 | 1 | 2021 | 6 | 0.050 |
Why?
| | Transferrin | 1 | 2021 | 37 | 0.050 |
Why?
| | Nutrition Disorders | 1 | 2021 | 22 | 0.050 |
Why?
| | Bacteroidetes | 1 | 2021 | 24 | 0.050 |
Why?
| | KCNQ1 Potassium Channel | 1 | 2021 | 7 | 0.050 |
Why?
| | Firmicutes | 1 | 2021 | 19 | 0.050 |
Why?
| | Animals | 3 | 2019 | 34350 | 0.050 |
Why?
| | Intra-Abdominal Fat | 1 | 2021 | 89 | 0.050 |
Why?
| | Remission Induction | 1 | 2021 | 264 | 0.050 |
Why?
| | Polymicrogyria | 1 | 2019 | 3 | 0.050 |
Why?
| | Waist Circumference | 1 | 2020 | 127 | 0.050 |
Why?
| | Neoplasms | 1 | 2014 | 2139 | 0.050 |
Why?
| | Fludrocortisone | 1 | 2009 | 4 | 0.050 |
Why?
| | Mice, Obese | 1 | 2009 | 60 | 0.050 |
Why?
| | Mineralocorticoids | 1 | 2009 | 3 | 0.050 |
Why?
| | Epithelial Sodium Channels | 1 | 2009 | 13 | 0.050 |
Why?
| | Renin | 1 | 2009 | 43 | 0.050 |
Why?
| | Citrates | 1 | 2009 | 56 | 0.050 |
Why?
| | Aldosterone | 1 | 2009 | 43 | 0.050 |
Why?
| | Dissection | 1 | 2009 | 54 | 0.050 |
Why?
| | Craniotomy | 1 | 2009 | 70 | 0.040 |
Why?
| | DNA Mutational Analysis | 2 | 2014 | 397 | 0.040 |
Why?
| | Pedigree | 2 | 2014 | 471 | 0.040 |
Why?
| | Vitamin D Deficiency | 1 | 2021 | 167 | 0.040 |
Why?
| | Feces | 1 | 2021 | 366 | 0.040 |
Why?
| | Pituitary Gland | 1 | 2009 | 169 | 0.040 |
Why?
| | Potassium | 1 | 2009 | 149 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2021 | 483 | 0.040 |
Why?
| | Sodium Chloride | 1 | 2009 | 157 | 0.040 |
Why?
| | Gene Frequency | 1 | 2019 | 418 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2020 | 577 | 0.040 |
Why?
| | Qualitative Research | 1 | 2022 | 856 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2021 | 496 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1052 | 0.040 |
Why?
| | Hospitals | 1 | 2021 | 540 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2019 | 623 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2021 | 671 | 0.040 |
Why?
| | Blotting, Western | 1 | 2009 | 1246 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 1807 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3214 | 0.040 |
Why?
| | Area Under Curve | 1 | 2016 | 314 | 0.040 |
Why?
| | Monitoring, Ambulatory | 1 | 2016 | 93 | 0.040 |
Why?
| | Electrocardiography | 1 | 2009 | 650 | 0.040 |
Why?
| | Decision Support Techniques | 1 | 2019 | 391 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2009 | 465 | 0.030 |
Why?
| | C-Peptide | 1 | 2015 | 132 | 0.030 |
Why?
| | Family Health | 1 | 2015 | 190 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 4842 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1155 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2504 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2438 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 1777 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2014 | 305 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 179 | 0.030 |
Why?
| | RNA | 1 | 2009 | 788 | 0.030 |
Why?
| | Mice | 2 | 2019 | 15537 | 0.030 |
Why?
| | Anthropometry | 1 | 2013 | 211 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2019 | 2805 | 0.030 |
Why?
| | Fruit | 1 | 2013 | 123 | 0.030 |
Why?
| | Vegetables | 1 | 2013 | 121 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2013 | 224 | 0.030 |
Why?
| | Self Concept | 1 | 2013 | 224 | 0.030 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 94 | 0.030 |
Why?
| | Syndrome | 1 | 2011 | 352 | 0.030 |
Why?
| | Liver | 1 | 2009 | 1856 | 0.030 |
Why?
| | Rituximab | 1 | 2011 | 171 | 0.020 |
Why?
| | Middle Aged | 3 | 2021 | 28659 | 0.020 |
Why?
| | Dietary Fats | 1 | 2013 | 353 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 2354 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1756 | 0.020 |
Why?
| | Energy Intake | 1 | 2013 | 516 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2009 | 5136 | 0.020 |
Why?
| | Immunologic Factors | 1 | 2011 | 230 | 0.020 |
Why?
| | Psychometrics | 1 | 2013 | 690 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2948 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 1971 | 0.020 |
Why?
| | Parents | 1 | 2015 | 1163 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2699 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2884 | 0.020 |
Why?
| | Lung Diseases | 1 | 2011 | 724 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2462 | 0.020 |
Why?
| | Autoantibodies | 1 | 2011 | 1292 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2004 | 295 | 0.010 |
Why?
| | Genetic Variation | 1 | 2004 | 801 | 0.010 |
Why?
| | Aged | 1 | 2004 | 20249 | 0.000 |
Why?
|
|
Kelsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|